A Multicenter, Prospective, Randomized, Open-label Study to Compare the Efficacy, Safety, and Tolerability of BOTOX and Topiramate for Headache Prophylaxis in Adults With Chronic Migraine
Phase of Trial: Phase IV
Latest Information Update: 26 Sep 2019
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Topiramate
- Indications Migraine
- Focus Therapeutic Use
- Acronyms FORWARD
- Sponsors Allergan
- 26 Sep 2019 Results assessing published in the Headache.
- 01 Jul 2018 Results (n=282) presented at the 60th Annual Scientific Meeting of the American Headache Society.
- 01 Jul 2018 Results presented at the 60th Annual Scientific Meeting of the American Headache Society